Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
910
Sort by:
Vaccines Market by Technology (Conjugate, Recombinant, Live Attenuated, Toxoid, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, HPV, Herpes Zoster, MMR, Rotavirus, RSV), Route of Administration - Global Forecast to 2029
US$ 3,217.50
The vaccines market (including COVID-19 vaccines) is projected to reach USD 94.9 Billion by 2029 from USD 78.0 Billion in 2024, at a CAGR of 4.0% during the forecast period. Similarly the vaccines mar...
April 2024
402 pages
Global Markets for Vaccine Technologies
US$ 4,650.00
... tables An overview of the global market for vaccine technologies Analyses of global market trends, with data from 2016 ... animals) and disease indications (infectious, cancer, and allergy) Examination of the industry environment, strategies, market influences, and driving forces Identification of regional market ...
January 2024
213 pages
Global Influenza Vaccines Market and Forecasts 2024 – 2032
US$ 2,450.00
The global influenza vaccines market size was valued at USD 7.8 Billion in 2023 and is likely to reach USD 13.7 Billion in 2032, expanding at a CAGR 7.2% during the forecast period. Several factors ar...
January 2024
310 pages
Vaccines Market by Technology (Recombinant, Toxoid, Conjugate, RNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Influenza, DTP, HPV, MMR, COVID-19), Route of Administration (IM, SC, Oral), End user (Pediatric, Adult) & Region - Global Forecast to 2028
US$ 4,950.00
... share of the market in 2018.” Based on type, the vaccines market is segmented into monovalent vaccines and multivalent vaccines. The monovalent segment ... the vaccines market. It aims at estimating the market size and future growth potential of this market across different segments such as technology, type ...
November 2023
371 pages
Vaccine Collaboration and Licensing Deals 2016-2023
US$ 3,995.00
... by the big pharma and big biotech companies of the world in terms of deals made. One of the key highlights of the report is that over 450 online deals records of actual vaccine deals ...
November 2023
400 pages
Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), Route of administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Type ( Human vaccine , Veterinary vaccine) - Global Forecast to 2028
US$ 3,217.50
... product launches in the vaccine adjuvants market Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the vaccine adjuvants market Market Development: Comprehensive information about emerging markets. This report analyzes the market for various vaccine adjuvants across geographies Market Diversification: Exhaustive information about new products ...
September 2023
231 pages
mRNA Vaccine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By mRNA Type (Nucleoside-modified mRNA, Unmodified mRNA, Self-Amplifying mRNA), By Application (COVID-19 mRNA Vaccines, Non COVID-19 mRNA Vaccines, Others), Region and Competition
US$ 4,500.00
Global mRNA vaccine market is poised to grow at an impressive rate during the forecast period on account of the various benefits of mRNA vaccine over DNA vaccine in terms of production, safety, effica...
August 2023
112 pages
Nasal Vaccines: Global Markets and Pipeline Analysis
US$ 5,500.00
Report : This report examines trends and sales in the global market for nasal vaccines through 2027. Leaders in the industry and their vaccine portfolios, the need for nasal vaccine development, compe...
December 2022
78 pages
Pediatric Vaccines: Global Markets
US$ 5,500.00
Report : This report highlights the current and future market potential of pediatric vaccines and a detailed analysis of the market’s drivers, challenges and opportunities. The report also covers mark...
September 2022
110 pages
United States Human Vaccines Market Size, Share, Top 45 Human Vaccines Brand In-depth Analysis, Emerging Trends, Current Analysis, Growth, Demand, Opportunity, and Forecast 2022 – 2028
US$ 1,889.00
Amid the COVID-19 crisis, the United States human vaccines market is poised to grow by US$ 31,517 million by 2028, accelerating at a CAGR of 7% during the forecast period. The prominent factors that a...
June 2022
215 pages
Influenza Vaccines: Global Markets
US$ 5,500.00
Report : The report explains critical trends in the influenza vaccine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakehold...
May 2022
109 pages
United States Influenza Vaccines Market: Focus on Persons Vaccinated, Pricing, Production, Supply, Promising Influenza Vaccines, Clinical Trials, Regulatory, Reimbursement, Distribution Channel, Major Deals, Key Players, Recent Developments – Size, Share, Trends, Analysis, Demand, Opportunity, and Forecast, 2022 – 2030
US$ 2,415.00
The United States Influenza Vaccines market size is expected to reach USD 7,007 million by 2030. It is expected to expand at a CAGR of 6.9% from 2021 to 2030. This new market report offerings an wide-...
February 2022
220 pages
Vaccines Market by Indication (Pneumococcal, Influenza, Rotavirus, Hepatitis, COVID-19), Route of Administration (Intramuscular, Subcutaneous, Oral), Type (Inactivated, Live Attenuated, Subunit Vaccines), Valence (Multivalent, Monovalent) - Global Forecast to 2028
US$ 2,922.00
Vaccines Market by Indication (Pneumococcal, Influenza, Rotavirus, Hepatitis, COVID-19), Route of Administration (Intramuscular, Subcutaneous, Oral), Type (Inactivated, Live Attenuated, Subunit Vaccin...
November 2021
229 pages
DNA Vaccines: Technologies and Global Markets
US$ 2,750.00
Report : The study’s scope includes DNA vaccine products that already are commercialized or likely to be in the next five years. Both human and animal health markets are studied. DNA vaccine delivery...
August 2021
113 pages
Global Influenza Vaccines Market, Persons Vaccinated, Impact of COVID-19, Company Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2027
US$ 2,590.00
The global influenza vaccines market is projected to exceed US$ 9.5 Billion mark by 2027, and is presenting ample opportunities to the industry’s players. Influenza viruses are considered as a major c...
July 2021
322 pages
Global Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial), Regional Forecasts 2021-2027
US$ 4,950.00
Global Vaccine Adjuvants Market is valued approximately at USD 0.70 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 10.5% over the forecast period 2021-2027. Vaccine...
July 2021
200 pages
Global Coronavirus Vaccine Market, By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV), By Vaccine Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid Vaccine, Protein Based Vaccine and Others), By Product Type (Monovalent Vaccine v/s Multivariant Vaccine), By Route of Administration (Intramuscular, Oral, Intranasal), By Patient Type (Adults v/s Pediatric), By End User (Hospitals, Clinics, Research Institutes, Others), By Region, Competition Forecast & Opportunities, 2026
US$ 4,500.00
Global coronavirus vaccine market is expected to grow at a robust rate in value terms to reach USD91325.46 million by the end of 2021. Coronaviruses are a group of viruses belonging to the coronavirid...
July 2021
119 pages
Global Neoantigen Cancer Vaccine Market, By Product (Personalized Neoantigen Vaccine, Off-the Shelf Neoantigen Vaccine), By Neoantigen Type (Synthetic Long Peptide (SLP), Nucleic Acid, Dendritic Cell, Tumor Cell), By Route of Administration (Intravenous, Intramuscular, Transdermal, Others), By Cell (Autologous, Allogenic), By Technology (RNA Sequencing, Whole Genome Sequencing, HLA Typing), By Delivery Mechanism (Liposomes, Virosomes, Electroporation, Gene gun, Others), By Application (Lung, Melanoma, Gastrointestinal, Brain Cancer, Others), By Region, Competition, Forecast & Opportunities, 2026
US$ 4,500.00
Global neoantigen cancer vaccine market is projected to grow with a CAGR of 54.18% during the forecast period and is expected to reach USD1754.44 million by 2026. The key factors responsible for the g...
July 2021
284 pages
